Difference between revisions of "Marine Biotechnology in Taiwan"
(Created page with "Go back to: Home > Strategies, Policies and Programmes > Asia == National strategy for biotechnology == The National Promotion Plan f...")
Revision as of 17:58, 8 March 2013
National strategy for biotechnology
The National Promotion Plan for the Biotechnology Industry was first published in 1995 and revised every 2 years since then. A ‘Diamond Action Plan for Taiwan Biotech Takeoff’ was established in 2009, building on the Act for Development of Biotech and New Pharmaceuticals Industry (2008). The main focus is on human health applications, including genomics, and on supporting the development of the most active biotech-focused venture capital and investment industry in Asia. The Biotech & Pharmaceutical Industries Program Office in the Ministry of Economic Affairs is responsible for supporting the Promotion Plan.
National strategy for marine biotechnology
There is no specific marine biotechnology strategy. Elements of marine bioresource development are present in three aspects of the ‘Newly Emerging Biotech’ sub-sector, specialized biotech, agricultural biotech and environmental biotech.
Centres of marine biotechnology research
Several universities are involved in marine biotechnology including: National Cheng Kung University;
The Institute of Marine Biotechnology  at National Dong Hwa University, working on industrial applications of marine bioresources using biotechnology, and marine biomedical developments, in collaboration with the Government institution NMMBA (the National Museum of Marine Biology and Aquarium ;
The National Sun Yat Sen University, which offers undergraduate and post-graduate courses in marine biotechnology ;
The Institute of Marine Biology at the National Taiwan Ocean University, researching ecology, taxonomy and utility of marine organisms, including natural products chemistry, with activities in marine plankton, crustacean, phycology and marine fungi and viruses .
This draft country profile is based on available online information sources and contributions from various country experts and stakeholders. It does not aim nor claim to be complete or final, but should be considered as a dynamic and living information resource that will be elaborated, updated and improved as more information becomes available, including further inputs from experts and stakeholders.
The information on this page is based on information initially compiled by Meredith Lloyd-Evans (BioBridge) as part of the CSA MarineBiotech Project activities (2011-2013).